Testosterone replacement therapy (TRT) typically decreases ejaculate volume, though the picture is more nuanced than a simple yes-or-no answer might suggest. The reduction stems mainly from the way exogenous testosterone suppresses the body’s own hormone signaling loop, which shrinks the testes and cuts off part of the fluid supply to the ejaculate. At the same time, some men on TRT report that their ejaculations feel stronger or more voluminous, creating a confusing gap between what the body actually produces and what the experience feels like.
Where Ejaculate Volume Actually Comes From
Most people assume sperm makes up the bulk of ejaculate, but sperm cells account for a tiny fraction of the total fluid. The two structures that produce nearly all of it are the seminal vesicles and the prostate gland. Research measuring the relative contributions found the seminal vesicles supply roughly 55–61% of the ejaculate while the prostate gland contributes about 37–44%.1PubMed Central. A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate The remaining small percentage comes from the testes themselves, the epididymides, and the bulbourethral glands.
Both the seminal vesicles and the prostate are heavily androgen-dependent organs, meaning they rely on testosterone and its more potent derivative, dihydrotestosterone (DHT), to grow, maintain their tissue, and produce secretions. In men with a rare genetic condition that impairs DHT production, semen samples are extremely low in volume, often less than 1 mL, with increased viscosity and poor liquefaction. That finding demonstrates just how central androgens are to the secretory output of these glands.2PubMed. Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency Animal research confirms this relationship at a mechanistic level: testosterone exerts dose-dependent control over both prostate weight and secretory volume.3PubMed. Determination of prostatic secretion in rats: effect of neurotransmitters and testosterone
So if the glands that produce ejaculate need testosterone to function, you might expect that adding more testosterone would increase volume. In isolation, that logic holds. But TRT does not act in isolation. It triggers a cascade of hormonal changes elsewhere in the body that work against that gland-stimulating effect.
How Exogenous Testosterone Suppresses Your Own Production
When you introduce testosterone from an outside source, your brain detects the elevated hormone levels and dials back its own signaling. Specifically, the hypothalamus reduces its output of gonadotropin-releasing hormone (GnRH), which in turn drops the pituitary gland’s secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This negative feedback loop is well established: exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, leading to reduced testosterone levels inside the testes and impaired sperm production.4PubMed Central. Clinician’s guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids
The testes do two jobs: they make testosterone and they make sperm. When LH and FSH drop, both functions suffer. The testes often shrink in size, and sperm production can slow to a trickle or stop entirely. While the testes contribute only a small fraction of total ejaculate fluid, the broader hormonal disruption matters. The intratesticular testosterone concentration, which is normally far higher than levels in the bloodstream, plummets on TRT even as blood levels rise. That local hormonal environment affects not just the testes but the epididymis and vas deferens, which contribute minor fluid components and help transport sperm into the ejaculate.5PubMed Central. Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
The net result is a tug-of-war. On one side, the higher circulating testosterone may support prostate and seminal vesicle secretions. On the other, the suppressed HPG axis reduces the testicular and epididymal contribution, and may also alter the overall coordination of the ejaculatory process. For most men on standard TRT, the suppressive side tends to win, resulting in a modest decrease in measurable ejaculate volume.
What the Clinical Trials Actually Show
The best direct evidence comes from a randomized controlled trial that specifically tested whether testosterone replacement improves ejaculatory dysfunction in men with low testosterone. The study measured ejaculate volume as a secondary outcome and found no difference between the testosterone group and the placebo group. Testosterone replacement was not associated with significant improvement in ejaculatory dysfunction in these androgen-deficient men.6The Journal of Clinical Endocrinology & Metabolism. Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial
This is worth sitting with, because many men start TRT expecting their sexual function to improve across the board. Erections often do improve. Libido frequently increases. But measured ejaculate volume? The trial data says it stays about the same or declines, at least in the context of standard replacement doses for men who were already low in testosterone.
Separately, when researchers looked at whether the form of testosterone matters, whether injections versus gels versus pellets might affect the outcome differently, they found no meaningful difference in semen parameters based on the delivery method.7PubMed. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy In other words, if you switch from testosterone cypionate injections to a topical gel hoping to preserve ejaculate volume, the evidence suggests it will not help.
The Perception Gap Between Measured and Felt Volume
Here is where things get genuinely interesting and a bit contradictory. A separate study testing a testosterone solution in hypogonadal men asked participants to rate their own ejaculatory experience using a validated questionnaire. The men on testosterone rated the amount or volume of their ejaculate significantly more favorably than men on placebo. They also rated the strength or force of ejaculation more positively. All three subjective ejaculatory function questions showed statistically significant improvements in the testosterone group compared to placebo.8The Journal of Sexual Medicine. Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men
So men feel like their ejaculations are more voluminous and forceful on TRT, even when objective measurements in another trial show no actual increase. What accounts for this disconnect? A few possibilities. Testosterone improves pelvic floor muscle tone and contractile strength, which can make the physical sensation of ejaculation more intense without changing the actual fluid volume. Testosterone also enhances libido and arousal, and more intense arousal before orgasm can create a subjective impression of a bigger release. The psychological component is real: when a man on TRT feels more energetic and sexually confident, that mental state colors his perception of ejaculatory quality.
For practical purposes, this means that if you start TRT and feel like your ejaculations are better, that experience is valid even if a lab measurement would not confirm a volume increase. But if your specific concern is producing a measurably larger volume of ejaculate, TRT alone is unlikely to deliver that.
Supraphysiologic Doses and Anabolic Steroids Make It Worse
If standard TRT doses cause a modest decline or no change, going beyond replacement levels pushes the scale decisively toward lower volume. Men using anabolic-androgenic steroids at bodybuilding doses experience significantly more suppression. A study of Egyptian male bodybuilders found that steroid users had significantly lower semen volume, lower sperm concentration, and lower total sperm counts compared to non-users.9QJM: An International Journal of Medicine. Effect of Anabolic-Androgenic Steroids on Semen Parameters and Serum Sex Hormonal Levels in Egyptian Male Bodybuilders
A systematic review covering the broader literature on anabolic steroid use and male fertility confirmed the pattern: men starting steroid cycles showed initial declines in semen volume, sperm concentration, total count, and motility. These declines persisted at the end of the cycle and at three-month follow-up, with recovery generally occurring by about one year after cessation.10PubMed Central. Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis The higher the dose and the longer the cycle, the more dramatic the suppression tends to be.
This is relevant because many men who self-administer testosterone do so at doses above what a doctor would prescribe for replacement. If you are injecting two or three times the amount needed to bring levels into the normal range, you are essentially on anabolic steroid doses as far as your HPG axis is concerned, and you should expect a more noticeable reduction in ejaculate volume.
Can You Prevent the Decline While Staying on TRT?
The most studied strategy is adding human chorionic gonadotropin (hCG) alongside testosterone. hCG mimics the action of LH, the pituitary hormone that TRT suppresses. By supplementing with hCG, you can keep the testes stimulated even while the brain’s own LH output drops. The same study that found no semen parameter differences across testosterone formulations also demonstrated that concurrent hCG injections preserved spermatogenesis in men on TRT.7PubMed. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy
A pilot study went further by combining testosterone with both hCG and recombinant FSH, evaluating whether this triple combination could maintain or improve semen parameters during continuous testosterone therapy.11The Journal of Sexual Medicine. Continuous Testosterone Therapy with Recombinant FSH & HCG Improves Semen Parameters: A Pilot Study This approach is still being studied, but the logic is straightforward: replace the hormonal signals that TRT eliminates so the testes keep doing their job.
For men whose primary concern is fertility rather than ejaculate volume per se, hCG co-administration is increasingly standard among endocrinologists and urologists who prescribe TRT to younger men. Whether it meaningfully preserves total fluid volume (as opposed to just sperm count) is less clear from the available trials, but maintaining testicular size and function should at least prevent the contribution of those glands from dropping to zero.
What About Clomiphene as an Alternative?
Some clinicians prescribe clomiphene citrate (a selective estrogen receptor modulator, or SERM) instead of testosterone, particularly for younger men who want to raise their testosterone levels without suppressing the HPG axis. Clomiphene works by tricking the brain into producing more LH and FSH, which then stimulates the testes to make more testosterone naturally. The theory is attractive: you get higher testosterone without shutting down your own production.
However, the evidence on ejaculate volume specifically is disappointing. A study tracking temporal changes in men taking clomiphene found that while testosterone levels rose and sperm concentration improved, semen volume did not improve at any time point during treatment.12PubMed Central. Temporal Changes of Clomiphene on Testosterone Levels and Semen Parameters in Subfertile Men This suggests that simply having more testosterone circulating does not automatically translate into greater fluid production from the seminal vesicles and prostate. The relationship between circulating hormone levels and gland output is not as linear as you might hope.
Recovery After Stopping TRT
If you have been on TRT and are concerned about decreased ejaculate volume, the good news is that the suppression is usually reversible. A review of the evidence on spermatogenesis recovery after TRT or anabolic steroid use concluded that cessation may result in spontaneous recovery in a reasonable number of patients, provided they are given sufficient time.13PubMed Central. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use As noted in the steroid literature, semen parameters including volume tend to recover by about one year after discontinuation for most men.10PubMed Central. Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis
That said, recovery is not guaranteed, and the timeline varies. Men who used higher doses for longer periods tend to take longer to bounce back. Some men, particularly those who used supraphysiologic doses for years, may not fully recover without medical intervention such as hCG or clomiphene therapy to restart the axis. Age also plays a role: older men generally have slower and less complete recovery than younger ones.
Other Medications That Compound the Problem
Many men on TRT also take other medications that can independently reduce ejaculate volume, and the combined effects may be more noticeable than either alone. Two common culprits deserve mention.
Finasteride and dutasteride, the 5-alpha reductase inhibitors prescribed for hair loss and enlarged prostate, directly reduce the conversion of testosterone to DHT. Since DHT is the primary driver of prostate secretion, these drugs decrease ejaculatory volume as an established side effect. Finasteride causes significant reduction in semen parameters, with reduced ejaculatory volume being the most consistently documented effect.14PubMed Central. Finasteride-its impact on sexual function and prostate cancer If you are taking both TRT and finasteride, you are experiencing HPG axis suppression from one drug while blocking the androgen pathway that stimulates prostatic fluid from the other. That combination can produce a noticeable drop in volume.
Alpha-blockers, commonly prescribed for urinary symptoms or high blood pressure, present a different issue. Depending on the receptor specificity and dose, these medications can decrease seminal emission or cause retrograde ejaculation, where semen flows backward into the bladder instead of out through the urethra.15Nature Reviews Urology. Adverse effects of common medications on male fertility A man on TRT who also starts an alpha-blocker like tamsulosin might attribute his decreased ejaculate to the testosterone when the real culprit is the newer medication.
What Men on TRT Can Realistically Expect
Pulling these threads together, here is the practical picture for someone starting or considering TRT:
- Measured volume: At standard replacement doses, ejaculate volume either stays flat or decreases modestly. A dramatic reduction is more common with higher doses or prolonged use.
- Subjective experience: Many men report that ejaculations feel stronger and more satisfying on TRT, likely due to improved pelvic muscle tone, higher arousal, and better overall sexual function.
- Delivery method: Injections, gels, and patches produce similar effects on semen parameters. Switching formulations will not preserve volume.
- Mitigation: Adding hCG can maintain testicular function and sperm production, which may help prevent the worst of the decline. The evidence for this preserving total fluid volume specifically is still thin, but it is the best available strategy.
- Reversibility: Most men recover semen parameters, including volume, within about a year of stopping TRT, though longer or heavier use can extend that timeline.
Why the Confusion Persists Online
If you search forums and social media for experiences with TRT and ejaculate volume, you will find wildly contradictory reports. Some men swear their volume increased. Others say it cratered. A few say nothing changed. Part of the confusion is the perception gap described earlier: feeling like more is coming out does not mean more is coming out. Part of it is dosing variability. A man on a conservative 100 mg per week prescription is in a different hormonal situation than a man injecting 300 mg every five days from an underground lab. And part of it is timing. Early in TRT, before HPG suppression fully sets in, a man whose previous low testosterone had been impairing his accessory gland function might genuinely see a brief uptick as those glands respond to the newly available androgen. Over weeks and months, as the suppressive effects accumulate, that initial bump fades.
The other major confounder is concurrent medication use. The man who started TRT, finasteride, and an alpha-blocker around the same time and then noticed lower volume has three potential causes, not one. Doctors do not routinely measure ejaculate volume at baseline before starting TRT, so there is rarely an objective before-and-after comparison to work from. Nearly all of what we know about individual men’s experiences is based on self-report, which is unreliable for estimating fluid volumes that differ by fractions of a milliliter.
For anyone who considers ejaculate volume personally important, the honest answer is that TRT is unlikely to help and may modestly hurt, but the change is often small enough that the subjective improvements in sexual function more than compensate in most men’s experience. If preserving volume is a high priority, discussing hCG co-administration with your prescribing physician before starting TRT is the most evidence-supported approach available.